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ABSTRACT 
Objective: Development and validation of two new, simple and specific analytical techniques for the simultaneous determination of a ternary 
mixture of co-administered cardiovascular drugs ticagrelor (TICA), irbesartan (IRB) and hydrochlorothiazide (HCT). 
Methods: Chemometric assisted UV spectrophotometric methods (considered as green analytical chemistry) and RP-HPLC method were developed 
and validated. The different applied chemometric methods are based on Fourier function convolution (FF) and Double divisor ratio spectra Fourier 
function (FFR). As for the HPLC method, it was developed on a C18 Sunfire© waters column with a mobile phase composed of Acetonitrile: sodium 
dihydrogen phosphate (adjusted to pH 3.6 using orthophosphoric acid) in the ratio of 60:40 v/v at a flow rate of 1 ml/min. Quantification was based 
on measuring peak areas at 230 nm. 
Results: By applying the chemometric assisted methods, good percentage recoveries were obtained in quantifying each of the drugs in their triple 
mixture. The RP-HPLC method, peaks were well resolved with retention times 4.6, 8.0 and 10.0 min, for HCT, TICA and IRB, respectively. The 
established method was also applied in samples spiked with plasma; the peaks were well separated from each other and from plasma protein peaks, 
proving the ability of the HPLC method to be applied in biological samples. The methods (RP-HPLC and chemometric assisted methods) were 
validated in terms of linearity, LOD, LOQ, precision and accuracy. The results obtained from the analysis of the co-administered mixture by the 
proposed chemometric assisted methods were statistically compared to those obtained by the applied RP-HPLC method. 
Conclusion: The applied RP-HPLC methods were proved to be more sensitive when compared to the applied chemometric methods, thus could be 
used for determination of drug concentration in human plasma. However, the applied chemometric methods, considered as green analytical 
chemistry, is a simple, time-saving method that requires minimal use of a hazardous solvent.  
Keywords: Fourier Function, Double divisor Fourier function ratio spectra, Spectrophotometry, RP-HPLC, Spiked plasma 
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INTRODUCTION 
Combination therapy (or polytherapy) is a broad term for the use of 
multiple medications, in order to fight a particular condition; It is a 
therapeutic intervention in which more than one pill (each 
containing separate drug) are administered to the patient. 
Cardiovascular disease (CVD) is the leading cause of death and disability 
worldwide. A dose combination therapy for the treatment of blood 
pressure, diuretic and antiplatelet treatments has been proposed as one 
strategy to reduce the global burden of CVD by remarkable percentage. 
So, developing a method for the estimation of a mixture of 
cardiovascular co-administered drugs would be of great importance [1]. 
Green analytical chemistry is concerned with the development of 
analytical procedures that minimize consumption of hazardous 
reagents and solvents, and maximize safety for operators and the 
environment. Therefore, chemometrics addresses the constraints that 
happen due to reducing the solvents used and the duration of analysis 
by doing most of the works on the front desk using microcomputers 
with appropriate software on the primary data generated in the lab 
work. After some recent years, chemometrics has become one of the 
mathematical and statistical techniques for the resolution of 
overlapping spectra of multi-component mixtures, which is difficult to 
separate using the traditional spectroscopic method as well as it has a 
wide application in different disciplines [1].  
Irbesartan (IRB), chemically described as 2-butyl-3-[[2′-(1H-
tetrazol-5-yl)[1,1′-biphenyl]-4-yl]-methyl1-3-diazaspiro-[4,4]-non-
1-en-4-one, (fig. 1), is an angiotensin II blocker, which acts mainly by 
selective blockade of AT1 receptors and reduces the effects of 
angiotensin II. IRB may be used alone or in combination with other 
antihypertensive or diuretic agents [2].  
Hydrochlorothiazide (HCT), chemically described as 6-chloro-3, 4-
dihydro-2H-1,2,4-benzothiadiazine-7-sulphonamide-1,1-dioxide, 
(fig. 2), is a thiazide diuretic. It increases sodium and chloride 
excretion in the distal convoluted tubule. Because of their 
synergistic antihypertensive action, irbesartan and hydro-
chlorothiazide are available in the market as a combined dosage 
form [2]. 
Ticagrelor (TICA), chemically described as (1S,2S,3R,5S)-3-[7-
{[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylthio)-
3H-[1,2,3]-tria zolo [4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxycyclo 
pentane-1,2-diol2, (fig. 3), is an orally active antiplatelet agent, act as 
an inhibitor for platelet activation and aggregation mediated by the 
P2Y12 ADP-receptor1. Ticagrelor is indicated to reduce the rate of 
cardiovascular thrombotic events in patients with the acute 
coronary syndrome. Ticagrelor and its major metabolite reversibly 
interact with the platelet P2Y12 ADP-receptor to prevent signal 
transduction and platelet activation, which inhibits platelet 
aggregation and thrombus formation in atherosclerotic disease [2]. 
Several analytical methods have been reported for the 
determination of irbesartan in pure drug, pharmaceutical dosage 
forms using spectrophotometry [3], RP-HPLC [4]. Also, irbesartan 
has been determined in human plasma by LC [5]. In the presence of 
hydrochlorothiazide, irbesartan has been determined by UV-
Spectroscopy [6], RP-HPLC [7, 8], HPLC by the aid of chemometry 
[9]. Hydrochlorothiazide and irbesartan are simultaneously 
determined by LC-MS in human plasma [10], or in spiked human 
plasma using microemulsion-LC [11]. Irbesartan, in combination 
with other drugs, has been determined by RP-HPLC [12], HPTLC 
[13], LC-MS [13]. 
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Hydrochlorothiazide has been determined individually by 
spectrophotometry [14], HPLC [15]. In combination with many 
other drugs, hydrochlorothiazide has been determined by HPLC [8, 
16, 13], spectrophotometric chemometric analysis [17, 18], HPTLC 
with UV-absorption densiometry [19]. 
Ticagrelor has been assayed by spectrophotometry [20], HPLC [21]. 
In plasma sample, ticagrelor has been determined by LC-MS [22], 
LC-MS-MS [23] and UPLC-MS [24]. 
To the best of our knowledge, neither of the already published 
papers has been related to any chemometric nor RP-HPLC method 
for simultaneous determination of HCT, TICA and IRB. So the 
present study emphasizes on the determination of HCT, TICA and 
IRB using different chemometric methods that will be compared to a 
RP-HPLC method. The developed methods will be validated 
according to ICH guidelines [25]. 
MATERIALS AND METHODS 
Apparatus 
The spectrophotometric measurements were carried out on a Jasco 
V-530 double beam UV-Vis Spectrophotometer connected to a 
computer loaded with Jasco UVPC software and HP Deskjet 5652 
printer. The absorption spectra were measured using 1-cm quartz 
cells. For DDRD, FF and FFR, the absorption spectra were recorded 
using 1 cm quartz cells. 
HPLC system (waters 1525) is composed of binary HPLC pump, 
connected to water 2487 dual wavelength absorbance detector. The 
liquid chromatographic system is equipped with waters 717 plus 
autosampler. Liquid separations are performed on RPC Sunfire © C18 
analytical column (250 x 4.6 mm x 5μm) at ambient temperature. The 
mobile phase used was degassed and filtered by passing through 0.5 μm 
pore size membrane filter at a pumping speed of 30L/min (Glassco 
diaphragm Vacuuum pump). The samples were also filtered using PTFE 
0.2 μm Minisart SRP 15 (Sartorius Stedim) disposable filters. 
Chromatographic conditions 
The mobile phase was prepared by mixing potassium dihydrogen 
phosphate buffer (adjusted to pH 3.6 with orthophosphoric acid) 
and acetonitrile in a ratio (40:60) by volume. 
Materials and reagents 
Ticagrelor (from supplied by Omnipharma, Astrazenica, Lebanon), 
irbesartan and hydrochlorothiazide (from Algorithm, Lebanon) 
were used as working standards. Acetonitrile (SIGMA-ALDRICH 
CHROMASOLV®FOR HPLC>99.9%), KH2PO4 (Merck KGaA), Na2HPO4 





Fig. 1: Irbesartan Fig. 2: Hydrochlorothiazide Fig. 3: Ticagrelor 
 
Chemometric assisted methods 
Standard stock solutions 
Standard solutions of TICA (1000 μg/ml, IRB (100 μg/ml) and HCT 
(400 μg/ml), were prepared separately in methanol.  
Working standard solutions 
Portions of the above stock solutions were separately diluted with 
methanol to attain the concentration of 100 μg/ml TICA, 10 μg/ml 
IRB and 40 μg/ml HCT. 
Calibration graphs  
Accurate volumes of the working standard solutions of TICA, IRB or HCT 
into separate sets of 10-mL calibrated flasks were transferred and 
completed to volume with methanol to obtain the concentration ranges 
stated in table 2. Absorbance values were recorded at λ range of 200-300 
nm for each drug, at 1 nm interval, against methanol as blank. 
Synthetic mixtures 
Six validation synthetic mixtures were prepared by mixing appropriate 
volumes of the working standard solutions of TICA, IRB and HCT and 
diluting to volume with methanol. The combination of TICA, IRB and 
HCT are illustrated in table 4. The absorbance values for each solution at 
1-nm intervals in the wavelength range 200-300 nm, were recorded. 
HPLC method 
Standard stock solutions 
Standard solutions of TICA (100 μg/ml), IRB (100 μg/ml) and HCT 
(100 μg/ml), were prepared in HPLC-grade methanol. 
Working standard solutions 
Portions of the above stock solutions were separately diluted with 
methanol to attain the concentration range of 10 μg/ml TICA, 1 
μg/ml IRB and 10 μg/ml HCT. 
Calibration graph 
Pure drugs 
Into series of 10-mL measured flasks, volumes from working 
solutions of TICA, IRB and HCT were transferred and diluted with 
methanol to give the final concentrations stated in table 3. The 
above solutions were filtered using 0.2 μm disposable filters. 20μL 
portions of the working solutions of TICA, IRB and HCT were 
injected in triplicates and chromatographed under the 
chromatographic conditions mentioned above. The peak area values 
of each drug were plotted against the corresponding concentrations 
to obtain the calibration graph for each drug. The concentrations of 
TICA, IRB and HCT from the corresponding calibration graphs were 
computed. 
Spiked plasma 
To calculated volumes of the working solutions of TICA, IRB and 
HCT, 100 μL of human plasma and 100 μL of acetonitrile were added 
(to deproteinize biological sample), to produce a final concentration 
in the range stated in table 3. After vortex mixing and centrifugation 
(6000 rpm/min), the supernatant solutions were filtered using 0.2 
μm disposable filters transferred to separate Eppendorf tubes and 
20 uL of each were injected into the HPLC column. The peak areas 
for each drug were measured and the corresponding concentrations 
in the mixtures were derived referring to calibration graph. 
Synthetic mixtures 
Pure drugs 
Accurate volumes of working standard solutions of TICA, IRB and 
HCT were transferred into a four separate 10-mL calibrated flasks 
and diluted to the mark with methanol to give synthetic mixtures 
containing IRB, HCT and TICA in the ratios stated in table 5. The 
solutions were filtered using 0.2 μm disposable filters. Volumes of 
20 μL portions of the mixture solutions were injected in triplicates 
and chromatographed under the chromatographic conditions 
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mentioned above. The peak areas for each drug were measured and 
the corresponding concentrations in the mixtures were derived 
referring to calibration graph. 
Spiked plasma 
Accurate volumes (from the supernatant layer obtained from 
centrifugation) of each drug were pipetted into Eppendorf tubes to 
give synthetic mixtures containing TICA, IRB and HCT in the ratios 
stated in table 5. Volumes of 20 μL portions of the mixture solutions 
were injected in triplicates and chromatographed under the 
chromatographic conditions mentioned above. The peak areas for 
each drug were measured and the corresponding concentrations in 
the mixtures were derived referring to calibration graph. 
RESULTS  
Chemometric assisted methods 
Spectral characteristics 
Fig. 4 represents the absorption spectra of TICA, IRB and HCT and their 
mixtures, recorded over the range of 200-300 nm against methanol. 
 
 
Fig. 4: Absorption curves of 1 μg/ml IRB in methanol, 8 μg/ml of 
HCT, 25 μg/ml TICA in methanol and their mixture 
 
Two chemometric methods, FF (Trigonometric Fourier function) and 
hybrid double divisor ratio spectra (FFR) were applied and validated. 
TICA was determined in presence of IRB and HCT by applying FF 
and FFR. The following equations were applied for FF (eq. 1) and 
FFR (eq. 2), respectively:  
tˊj = [(1.707) A0+(0.707) A1+(-0.707) A2+(-1.707) A3+(-1.707) A4+(-
0.707) A5+(0.707) A6+(1.707) A7]/4……. (1) 
Where A0–A7 stand for eight absorbance values at 4-nm intervals for 
20 μg/ml TICA, 2 μg/ml IRB+6 μg/ml HCT (that is the double 
divisor) and their mixtures within the range (240-268 nm). The 
number in brackets are the selected combined Fourier functions and 
Tˊ= [cos xi+cos (xi+45 °)] (fig. 5).  
tˊj = [(-0.866) FFR0+(0) FFR1+(0.866) FFR2+(0.866) FFR3+(0) FFR4-
(0.866)FFR5]/3…. (2) 
Where R0–R5 stand for six ratio values at 4-nm intervals for 20 
μg/ml TICA, 2 μg/ml IRB+6 μg/ml HCT (that is the double divisor) 
and their mixtures within the range (244-264 nm). The number in 
brackets are the selected combined Fourier functions and Tˊ= [sin xi-
sin (xi+60 °)] (fig. 6). 
IRB was also determined in the presence of TICA and HCT by 
applying FF and FFR. The following equations were applied for FF 
and FFR, (eq. 3, 4) respectively:  
tˊj = [(-0.866) A0+(1.732) A1-(00866) A2-(0.866) A3+(1.732) A4-
(0.866) A5]/4…………. (3). 
Where A0–A5 stand for six absorbance values at 4-nm intervals for 3 
μg/ml IRB, 8 μg/mlTICA+20 μg/ml HCT and their mixtures within 
the range (204-224 nm). The number in brackets are the selected 
combined Fourier functions and T ˊ= [sin xi-sin (2xi+60 °)] (fig. 7). 
tˊj = [(-0.866) FFR0+(0) FFR1+(0.866) FFR2+(0.866) FFR3+(0) FFR4-
(0.866) FFR5]/3 ….…(4) 
Where R0–R5 stand for six ratio values at 4-nm intervals for 3 μg/ml 
IRB, 8 μg/ml TICA+20 μg/ml HCT (that is the double divisor) and 
their mixtures within the range (240-260 nm). The number in 
brackets are the selected combined Fourier functions and Tˊ= [sin xi-
sin (xi+60 °)] (fig. 8). 
 
 
Fig. 5: Fourier functions convoluted curves for 25 μg/ml TICA in 
methanol, 2 μg/ml IRB+6 μg/ml HCT in methanol and their mixture 
 
 
Fig. 6: Fourier functions convolution of ratio for 25 μg/ml TICA in 
methanol, 2 μg/ml IRB+6 μg/ml HCT in methanol and their mixture 
 
 
Fig. 7: Fourier functions convoluted curves for 3 μg/ml IRB in 
methanol, 8 μg/ml HCT+20 μg/ml TICA in methanol and their 
mixture 
 
HCT was finally determined in presence of TICA and IRB by applying 
FF and FFR. The following equations were applied for FF and FFR, 
(eq. 5, 6) respectively:  
tˊj = [(1.5) A0+(0) A1+(-1.5) A2+(-1.5) A3 (0) A4+(1.5) A5]/3…………. (5) 
Where A0–A5 stand for six Absorbance values at 4-nm intervals for 
10 μg/ml HCT, 2 μg/ml IRB+20 μg/ml TICA (that is the double 
divisor) and their mixtures within the range (212-232 nm). The 
Jamal et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 8, 243-250 
 
246 
number in brackets are the selected combined Fourier functions and 
Tˊ= [sin xi-sin (xi+60 °)] (fig. 9). 
tˊj = [(-0.866) FFR0+(0) FFR1+(0.866) FFR2+(0.866) FFR3+(0) FFR4-
(0.866) FFR5]/3 … (6) 
 
 
Fig. 8: Fourier functions convoluted curves of ratio for 3 μg/ml 
IRB in methanol, 8 μg/ml HCT+20 μg/mlTICA in methanol and 
their mixture 
 
Where R0–R5 stand for six ratio values at 4-nm intervals for 10 
μg/ml HCT, 2 μg/ml IRB+20 μg/ml TICA (that is the double divisor) 
and their mixtures within the range (240-260 nm). The number in 
brackets are the selected combined Fourier functions and Tˊ= [sin xi-
sin (xi+60 °)] (fig. 10). 
 
 
Fig. 9: Fourier functions convoluted curves for 10 μg/ml HCT, 2 
μg/ml IRB+20 μg/ml TICA in methanol and their mixture 
 
 
Fig. 10: Fourier functions convoluted curves of ratio for 10 μg/ml 
HCT, 2 μg/ml IRB+20 μg/ml TIC in methanol and their mixture 
 
DISCUSSION  
Chemometric assisted methods 
As fig. 4 shows, there is clear spectral overlapping, preventing their 
resolution by direct traditional spectrophotometric measurements. 
Thus, the applied a chemometric assisted methods showed their 
ability to quantify each of the drugs in their ternary mixture. 
The FF method depends on the convolution of absorption spectra of 
TICA, IRB and HCT using combined trigonometric Fourier function 
(FF). Following the general rules for the use of Fourier function in 
the processing of the absorption spectral data [26, 27], the 
associated different parameters were optimized. FFR method that is 
considered as a hybrid double divisor ratio spectra method depends 
on the convolution of the double divisor ratio spectra (to cancel the 
interfering effect of other drugs in the mixture, and obtain better 
resolution) using trigonometric Fourier functions, wherein this 
method, Fourier functions are applied to double divisor ratio 
spectra.  
The optimum parameters were selected for each drug in order to 
give precise and accurate results for the analyte in the presence of 
the other interfering drugs. These include the selection of function 
order, number of points and wavelength intervals corresponding to 
spectral characteristics. Both methods gave good % recoveries. 
However, the application of the hybrid method (FFR) proved its 
excellence in resolving this triple mixture (table 4). 
HPLC method 
Optimization of chromatographic conditions 
To establish and validate an accurate method for the analysis of 
these drugs in pharmaceutical formulations and plasma, C18 column 
was used. The effect of mobile phase composition, flow rate, and pH 
were studied. The best resolution with reasonable retention time 
was obtained with a mobile phase composed of acetonitrile: 
phosphate buffer in the ratio of (60:40). 
Upon studying the effect of pH of the aqueous mobile phase, strongly 
acidic pH values gave peaks of short retention time that interfered 
with plasma protein peak. However, alkaline pH gave very long 
retention time. The best separation in terms of system suitability 
and the resolution was achieved by using the value of pH of 3.6. The 
optimum wavelength for detection was 230 nm at which much 
better detector response for HCT, TICA and IRB was obtained. 
According to FDA 1994 [28], system suitability tests are an integral 
part of any liquid chromatographic method. System suitability uses 
to verify capacity factor, number of theoretical plates, asymmetry 
factor, selectivity and resolution (table 1) and they were found to be 
satisfactory and within the reported acceptance criteria listed in the 
reference  
The optimum chromatographic conditions mentioned previously 
were applied for all measurements. Fig. 11, shows the separation of 
HCT at 4.8 min, TICA at 7.9 min and IRB at 9.8 min, at the optimized 
chromatographic conditions. Fig. 12, shows the separation of HCT at 
4.4 min, TICA at 8.0 min and IRB at 9.9 min, in spiked plasma at the 
optimized chromatographic conditions. 
 
 
Fig. 11: HPLC chromatogram of a 20 µl injection of a standard 
mixture of 0.3 μg/ml TICA, 0.05 μg/ml IRB, and 0.5 μg/ml HCT 
using the optimized chromatographic conditions 
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Fig. 12: HPLC chromatogram of a 20 µl injection of a mixture of 
0.3μg/ml TICA, 0.05 μg/ml IRB, and 0.5 μg/ml HCT in spiked 
plasma using the optimized chromatographic conditions 
 
Method validation and statistical analysis [25, 29] 
The proposed methods were validated according to ICH guidelines 
[25]. The validation parameters included: linearity, limits of 
detection and quantification, accuracy, precision and specificity. The 
applied analytical methods are able to separate and quantify the 
studied drugs in their triple mixture. 
Linearity and concentration ranges 
Under the described experimental conditions, the graphs obtained 
by plotting the signals of the proposed methods versus 
concentration for TICA, IRB and HCT gave linear relationships over 
the concentration ranges stated in table 2 and 3. Linearity data and 
statistical parameters for the proposed methods were calculated, 
including linear regression equation parameters (intercepts, slopes, 
correlation coefficients, the standard deviation of intercept and 
standard deviation of the slope (table 2 and 3). Regression analysis 
confirmed good linearity as shown from correlation coefficient value 
(r>0.999). The high F-value proved that the linear correlation 
between calculated signals (chemometric methods) or peak areas 
(HPLC method) and concentrations in significance to a high level 
of confidence. The high values of the correlation coefficient (r) 
with negligible intercepts indicate the good linearity of the 
calibration graphs. The standard deviation of residuals (Sy/x), of 
intercept (Sa) and of slope (Sb) are presented for each drug. (Sy/x) 
is a measure of the extent of deviation of the found (measured) y-
values from the calculated ones. Also, the small degree of 
scattering of the experimental data point around the line of 
regressions was confirmed by the small values of the variances 
around the slopes (Sb2). 
 
Table 1: HPLC system suitability parameters for the determination of HCT, TICA and IRB using the proposed method 
Analyte Retention time (tr) Capacity 
Factor(kˊ) 
No of theoretical plates (N) Asymmetry factor (AF) Selectivity (α) Resolution (Rs) 




2.20 TICA 7.9 1.72 1198 1.16 
IRB 9.8 2.38 1433 1.00 
 
Limit of detection (LOD) and limit of qualification (LOQ) 
Limits of detection (LOD) and quantification (LOQ) were calculated 
according to the ICH guidelines [25]. LOD was defined as 10 Sa/b, 
where Sa is the standard deviation of the intercept and b is the slope 
of the calibration curve. The sensitivity of the proposed methods can 
be confirmed by the low LOD and LOQ values obtained in table 2. 
The variance test for the regression lines revealed that, for equal 
degrees of freedom, the increase in the variance ratio (F-values) 
means an increase in the mean squares due to regression and a 
decrease in the mean squares due to residuals, (i. e the less is the 
scatter of experimental points around the regression line). 
 Consequently, regression lines with high F-values (low significance 
F) are much better than those with lower ones. Good regression 
lines show high values for both r and F statistical parameters [30]. 
  
Table 2: Assay parameters for the determination of TICA, IRB and HCT using the applied chemometric assisted methods 
 TICA IRB HCT 
Conc. Range(μg/ml) 10-30 1-3 4-10 
Parameters FF FF FF FFR FFR FFR 
λ or λ range(nm) 240-268 204-224 212-232 212-232 240-260 244-264 
Δλ(nm) 4 4 4 4 4 4 
r 0.9997 0.9993 0.9993 0.9992 0.9992 0.9998 
S y/x 7.00 x 10-7 2.75 x 10-6 2.77 x 10-[34] 8.44 x 10-[34] 3.09 x 10-5 1.89 x 10-7 
F 65 x 103 2299 1.02 x 10[33] 9.82 x 10[31] 2044 97 x 103 
Significance F 1.31 x 10-7 2.00 x 10-5 6.75 x 10-[50] 2.27 x 10-[48] 2.38 x 10-5 7.24 x 10-8 
a (intercept) -0.03 x 10-2 0.28 x 10-3 0.2 x 10-[16] 5.55 x 10-[17] 0.65 x 10-2 -0.17 x 10-3 
b (slope) -0.78 x 10-1 0.29 x 10-1 0.48 x 10-1 0.26 x 10-1 0.159 0.49 x 10-1 
Sa 0.68 x 10-3 0.13 x 10-2 1.01 x 10-[17] 1.76 x 10-[17] 0.74 x 10-2 0.33 x 10-3 
Sb 0.31 x 10-3 0.61 x 10-3 1.52 x 10-[18] 2.65 x 10-[18] 0.35 x 10-2 0.159 x 10-3 
LOD (μg/ml) -0.24 x 10-1 -0.24 x 10-1 6.22 x 10-[16] 2.01 x 10-[15] 0.14 0.20 x 10-1 
LOQ (μg/ml) -0.82 x 10-1 0.44 2.07 x 10-[15] 6.69 x 10-[15] 0.46 0.67 x 10-1 
a/Sa -0.46 0.22 1.98 3.15 0.88 -0.49 
(Sb)2 9.33 x 10-8 3.66 x 10-7 2.31 x 10-[36] 7.03 x 10-[36] 1.24 x 10-5 2.52 x 10-8 
Sb % 9.33 x 10-6 3.66 x 10-5 1.52 x 10-[16] 2.65 x 10-[16] 1.24 x 10-3 2.52 x 10-8 
 
Accuracy and precision 
The applicability of the developed methods was tested by the 
analysis of TICA, IRB and HCT in several synthetic mixtures of 
different proportions on the same day and on different days. Good 
accuracy expressed as relative percentage error (Er %), and high 
precision, expressed as percentage RSD, were obtained. The results, 
summarized in tables 4, 5 and 6 show that the (Er %) and RSD % 
values do not exceed the accepted limits, which demonstrate the 
accuracy an repeatability of the developed methods. 
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Table 3: Assay parameters for the determination of HCT, TICA and IRB using the proposed HPLC method 
Parameters HCT IRB TICA HCT IRB TICA 
In pure drugs In spiked plasma 
Conc. Range (μg/ml) 0.1-0.9 0.01-0.05 0.1-0.5 0.1-0.9 0.01-0.05 0.1-0.5 
Δλ(nm) 230 230 230 230 230 230 
r  0.9999 0.9993 0.9996 0.9999 0.9858 0.9996 
S y/x 25.51 x 104 74.04 x 106 48.35 x 102 76.73 x 104 78.62 x 106 11.04 x 103 
F 74.53 x 103 23.34 x 102 40.40 x 103 24.40 x 103 103.69 16.29 x 103 
Significance F 1.08 x 10-7 1.95 x 10-5 2.71 x 10-7 5.78 x 10-7 2.02 x 10-3 1.06 x 10-6 
a (intercept) -17.20 23.33 x 102 -29.40 255.75 -16.36 x 103 -87.3 
b (slope) 12.58 x 104 24.00 x 104 25.52 x 104 12.49 x 104 28.55 x 104 24.48 x 104 
Sa 264.84 16.47 x 102 42.11 459.34 92.99 x 102 63.61 
Sb 461.04 49.67 x 102 12.69 x 102 799.62 28.04 x 103 19.18 x 102 
LOD (μg/ml) 0.631 x 10-2 0.205 x 10-1 0.495 x 10-3 0.11 x 10-3 9.77 x 10-2 7.79 x 10-4 
LOQ (μg/ml) 0.21 x 10-1 0.686 x 10-1 0.165 x 10-2 3.67 x 10-2 0.33 2.59 x 10-3 
a/Sa -0.64 x 10-1 1.41 -0.698 0.556 -1.76 -1.37 
Sb2 21.25 x 104 24.67 x 106 16.11 x 105 63.93 x 104 7.86 x 108 36.78 x 105 
Sb % 46.10 x 103 13.94 x 104 12.69 x 104 79.96 x 103 28.04 x 105 19.18 x 104 
 
Table 4: Accuracy for the simultaneous determination of TICA, HCT o IRB in laboratory-made mixtures using the proposed chemometric 
assisted methods 
TICA: IRB: HCT  μg/ml Mean recovery±SDa, RSD %b, Er %c 
FF FFR 









10:3:4 98.66±1.56 100.00±0.73 
1.58 0.73 
-1.34 0.00 
20:3:10 97.99±0.92 100.65±0.99 
0.94 0.98 
-2.01 0.65 
3:30:10 101.24±0.92 100.00±0.99 
0.90 0.99 
1.24 0.00 
15:2:10 97.00±0.89 100.48±0.54 
0.91 0.54 
-3.0 0.48 
amean±SD for the three determinations, b% Relative standard deviation, c% Relative error 
 
Table 5: Accuracy for the simultaneous determination of IRB, HCT and TICA in laboratory-made mixtures and spiked plasma using the 
proposed HPLC method 
HCT: IRB: TICAμg/ml Mean recovery±SDa, RSD%b, Er%c 
HCT IRB TICA HCT IRB TICA 
In laboratory prepared mixtures In spiked plasma 
0.1:0.01: 0.1 98.75±0.86 99.38±0.87 101.64±1.73 99.39±0.99 100.90±1.02 100.16±1.11 
0.87 0.87 1.70 0.99 1.01 1.11 
0.39 -0.62 1.64 -0.61 1.02 0.16 
0.3:0.02:0.2 98.92±0.98 98.20±1.52 100.09±1.25 99.44±0.89 101.47±0.85 101.46±0.86 
0.99 1.55 1.25 0.89 0.84 0.851.46 
0.58 -1.8 0.09 -0.26 1.47  
0.5:0.03:0.3 99.47±1.18 99.61±1.34 101.10±0.68 99.68±1.48 101.56±0.61 100.10±0.68 
1.18 1.35 0.67 1.48 0.60 0.68 
-0.53 -0.39 1.10 -0.32 1.56 0.10 
0.7:0.04:0.4 99.6±1.09 99.82±0.88 100.50±1.32 98.88±1.57 100.04±0.76 101.20±0.32 
1.09 0.88 1.31 1.59 0.76 0.32 
-0.40 -0.18 0.48 -1.70 3.44 1.20 
0.9:0.05:0.5 98.98±1.09 99.26±1.09 100.56±1.32 99.34±0.87 101.04±0.98 100.05±0.87 
1.10 1.09 1.31 0.88 0.97 0.87 
-1.02 -0.74 0.56 -0.66 1.01 0.05 
amean±SD for the five determinations, b% Relative standard deviation, c% Relative error 
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Table 6: Intra-day and inter-day precision for the simultaneous determination of TICA, IRB and HCT in laboratory-made mixtures using 
the proposed chemometric and HPLC methods 




Intra-day precision, Mean recovery±SDa 
RSD%b, Er%c 
Inter-day precision, Mean recovery±SDa 
RSD%b, Er%c 
TICA  IRB HCT TICA  IRB HCT 






















































amean±SD for the five determinations, b% Relative standard deviation, c% Relative error 
 
Table 7: Assay results for TICA, IRB and HCT in their laboratory made mixture using the proposed methods 
RatioTICA+IRB+HCTμg/ml9:1.5:0.5 Mean recovery±SDaRSD %bEr %c 
 HPLC FF FFR 
TICA    
Mean Recovery±SDa 98.76±0.45 98.87±0.40 99.19±1.09 
RSD %b 0.45 0.40 1.09 
Er %c -1.01 -1.13 -0.81 
**t-test –– 0.43 0.82 
**F-test –– 0.79 5.86 
IRB    
Mean Recovery±SDa 98.99±0.87 99.35±0.71 99.82±0.70 
RSD %b 0.87 0.71 0.70 
Er %c -1.01 -0.65 -0.18 
**t-test –– 0.71 1.67 
**F-test –– 0.69 0.65 






amean±SD for the five determinations, b% Relative standard deviation, c% Relative error, **Theoretical values of t-and F-at P = 0.05 are 2.13 and 
6.93, respectively. 
 
Laboratory made mixture 
Table 7 present a statistical comparison between the assay of TICA, 
IRB and HCT in the laboratory made a mixture by the proposed 
methods using the student’s t-test and the variance ratio F-test. 
Since the calculated t-and F-values for each drug did not exceed the 
theoretical ones, this indicated that there was no significant 
difference between the applied methods for determination of the 
two drugs in commercial tablets. 
CONCLUSION 
For analytical purposes, it is always important to establish methods 
capable of analyzing co-administered drugs in a short period of time 
with acceptable accuracy and precision. The chemometric assisted 
methods are simple, inexpensive and require easy treatment of the 
samples. The use of ratio spectra in the chemometric methods can 
magnify the prediction ability of the usual Spectrophotometric 
techniques. A comparative study of the use of RP-HPLC and 
chemometric assisted methods for resolution of ticagrelor, 
irbesartan, hydrochlorothiazide has been accomplished. Showing 
that chemometric assisted methods provide, with adequate software 
support, a clear example of the high resolving power of this 
technique. Although the RP-HPLC method is more sensitive, it needs 
expensive equipment and materials. The chemometric assisted 
methods are less expensive and do not require sophisticated 
instruments or prior separation steps. The proposed RP-HPLC were 
found to be suitable for the assay of this ternary mixture in plasma 
and can be used for further bioequivalence studies.  
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